Yfc. Vanrenterghem, Which calcineurin inhibitor is preferred in renal transplantation: tacrolimus or cyclosporine?, CURR OP NEP, 8(6), 1999, pp. 669-674
Cyclosporine and tacrolimus are potent inhibitors of the calcineurin-depend
ent cytokine synthesis in activated lymphocytes. In renal transplant patien
ts tacrolimus is more powerful in preventing severe and refractory rejectio
ns, even when compared with the new cyclosporine microemulsion formulation.
Both drugs are equally nephrotoxic, but tacrolimus induces less hypertensi
on and less pronounced hyperlipidaemia, Especially in some categories of pa
tients, a higher incidence of de-novo diabetes mellitus is seen with tacrol
imus therapy. Curr Opin Nephrol Hypertens 8:669-674. (C) 1999 Lippincott Wi
liiams & Wilkins.